Other components and pathways that are positively associated with CCL2 granule in IPF patients include azurophil granule and several immune-related pathways, such as allograft rejection, asthma, graft-versus-host disease and viral protein interaction with cytokine and cytokine receptor (Fig. 6b,d). This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.